Superoxide dismutase (Weizmann Institute)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSuperoxide dismutase (Weizmann Institute)
Drug Alias NameOxSODrolrhSOD1
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionSuperoxide dismutase stimulants
TargetsSuperoxide dismutase
Therapy Area/IndicationsMyocardial IschemiaAmyotrophic Lateral SclerosisRespiratory Distress Syndrome, Newborn +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWeizmann Institute Of Science
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWeizmann Institute Of ScienceJcr Pharmaceuticals Co LtdMerck Serono
Active IndicationsN/A
Inactive IndicationsMyocardial IschemiaAmyotrophic Lateral SclerosisRespiratory Distress Syndrome, Newborn +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG